It offers a dynamic platform for clinicians and patients to enter critical patient data, such as age, hormone receptor status, and tumor characteristics, and explore various treatment options, including surgery, antiestrogen therapy, and radiotherapy. This evidence concerns the gene NR4A1 and neoplasm.